0001077183-21-000082.txt : 20210303 0001077183-21-000082.hdr.sgml : 20210303 20210303201741 ACCESSION NUMBER: 0001077183-21-000082 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210301 FILED AS OF DATE: 20210303 DATE AS OF CHANGE: 20210303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SHOVLIN ROBERT J. CENTRAL INDEX KEY: 0001621453 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35756 FILM NUMBER: 21711943 MAIL ADDRESS: STREET 1: 12701 COMMONWEALTH DRIVE CITY: FORT MYERS STATE: FL ZIP: 33913 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEOGENOMICS INC CENTRAL INDEX KEY: 0001077183 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-TESTING LABORATORIES [8734] IRS NUMBER: 742897368 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12701 COMMONWEALTH DRIVE STREET 2: SUITE 9 CITY: FORT MYERS STATE: FL ZIP: 33913 BUSINESS PHONE: 9419231949 MAIL ADDRESS: STREET 1: 12701 COMMONWEALTH DRIVE STREET 2: SUITE 9 CITY: FORT MYERS STATE: FL ZIP: 33913 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN COMMUNICATIONS ENTERPRISES INC DATE OF NAME CHANGE: 19990120 4 1 wf-form4_161482063651429.xml FORM 4 X0306 4 2021-03-01 0 0001077183 NEOGENOMICS INC NEO 0001621453 SHOVLIN ROBERT J. 12701 COMMONWEALTH DRIVE SUITE 9 FORT MYERS FL 33913 0 1 0 0 President, Clinical Services Common Stock 2021-03-01 4 F 0 742 0 D 147528 D Common Stock 2021-03-02 4 F 0 608 0 D 146920 D Common Stock 2021-03-02 4 A 0 6827 0 A 153747 D Stock Option (Right to Buy) 8.03 2023-02-26 Common Stock 96167.0 96167 D Stock Option (Right to Buy) 19.6 2024-03-01 Common Stock 50173.0 50173 D Stock Option (Right to Buy) 28.33 2027-03-02 Common Stock 56271.0 56271 D Stock Option (Right to Buy) 53.17 2021-03-02 4 A 0 38688 53.17 A 2028-03-02 Common Stock 38688.0 38688 D Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 1, 2021 vesting of restricted stock. Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 2, 2021 vesting of restricted stock. On February 26, 2018, Mr. Shovlin was granted 288,500 stock options. These options vested ratably over the first three anniversary dates of the grant date. On March 1, 2019, Mr. Shovlin was granted 66,897 stock options. These options vest ratably over the first four anniversary dates of the grant date. On March 2, 2020, Mr. Shovlin was granted 56,271 stock options. These options vest ratably over the first four anniversary dates of the grant date. On March 2, 2021, Mr. Shovlin was granted 38,688 stock options. These options vest ratably over the first four anniversary dates of the grant date /s/ Robert J. Shovlin 2021-03-03